Beckman Coulter, Inc. and Biosite, Inc. have announced an agreement whereby Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer of $85 per share, or approximately $1.55 billion on a fully diluted share basis, as detailed below. It is currently expected that the transaction will close in the second quarter of 2007. Latham & Watkins LLP represents Beckman Coulter with a corporate team led by partner Paul Tosetti in Los Angeles and partners Cary Hyden and Jonn Beeson in Orange County, with associates David C. Lee, Bjorn Johnson, Darcy Down and Bryan Zech.  Los Angeles partners Mary Ruhl and Cici Rotell and associate Brian Agboh are advising on financing matters; Los Angeles partner Laurence Stein and associate Pardis Zomorodi on tax; Los Angeles partner James Barrall and associate Cynthia Kao on benefits; Washington, D.C. partner Tad Lipsky and of counsel Sydney Smith, with San Francisco partner Karen Silverman and associate Joshua Holian on antitrust; Orange County partner Joseph Farrell on labor; Orange County of counsel Christopher Norton on environmental issues; Silicon Valley partner Anthony Klein on intellectual property; Los Angeles partner Manny Abascal on litigation diligence; and Washington, D.C. partners John Manthei and Carolyne Hathaway with associate Seth Mailhot on regulatory issues.

www.lw.com